New Study Reveals U.S. Businesses Average Over 5 Major Outages Annually, with 63% Occurring During Critical Peak Trading Times Philadelphia, PA and Boston, MA, Jan. 12, 2026 (Korea Bizwire) – A new study released today reveals that payment system failures are putting $44.4 billion in U.S. retail and hospitality sales at risk each year, underscoring how quickly [...]
Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany– 12 January, 2026 – Boehringer Ingelheim today announced a strategic clinical collaboration with Jazz Pharmaceuticals (Nasdaq: JAZZ) on the exploration of a novel combination therapy for patients with HER2-positive breast cancer. As part of this collaboration, the partners will [...]
SÃO PAULO and ATLANTA, Jan. 12, 2026 (Korea Bizwire) – Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Supergasbras, one of the leading distributors in the Brazilian liquefied petroleum gas (LPG) market, has modernized its logistics operations using Descartes’ cloud-based route planning and fleet management solution. The [...]
Investment industry veteran Mr. Brian Cherry appointed to Board of Directors Dr. Sabeen Mekan to transition to Chief Medical Officer effective February 1, 2026 and Mark Hollywood promoted to Executive Vice President and Chief Operating Officer Five new Vice Presidents appointed, underscoring our commitment to leadership development VANCOUVER, British Columbia, Jan. 12, 2026 (Korea Bizwire) [...]
Chua will spearhead Health-ISAC’s expansion into the APAC region, enhancing cybersecurity and resilience in the global health sector SINGAPORE, Jan. 11, 2026 (Korea Bizwire) – Health Information Sharing and Analysis Center (Health-ISAC) is pleased to announce the appointment of Paul Chua as its new Asia Pacific (APAC) Operations Director. In this pivotal role, Mr. Chua [...]
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone payments eligible to be earned related to regulatory approvals of Ziihera in GEA in the United States, Europe, Japan, and China Company well-positioned to execute new strategy compounding long-term value by integrating royalty [...]
Richard Francis, Teva’s President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time) TEL AVIV, Israel, Jan. 11, 2026 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present its ongoing transformation and expected growth trajectory [...]
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate TEV-‘408 TEV-‘408 is currently in Phase 1b for treatment of vitiligo and in Phase 2a for celiac disease Funding agreement supports Teva’s Pivot to Growth [...]
Launch of V Gallant’s Co-Working Data Center and IDEX Exchange Hub Signals Convergence of High-Performance Compute and Physical AI Infrastructure KUALA LUMPUR, Malaysia, Jan. 09, 2026 (Korea Bizwire) – VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), through its artificial intelligence subsidiary V Gallant Limited (“V Gallant”), today announced that its first Enterprise [...]
TAMPA, Fla., Jan. 09, 2026 (Korea Bizwire) – AACSB International today released exposure drafts of its inaugural Global Standards for Business Education and 2026 Accounting Accreditation Standards inviting feedback from business schools, faculty, students, employers, higher education associations, and other stakeholders worldwide. The new Global Standards for Business Education, a revision of AACSB’s highly respected Accreditation Standards, are designed to [...]